Cite
CRB2 enhances malignancy of glioblastoma via activation of the NF-κB pathway.
MLA
Wang, Yichang, et al. “CRB2 Enhances Malignancy of Glioblastoma via Activation of the NF-ΚB Pathway.” Experimental Cell Research, vol. 414, no. 1, May 2022, p. N.PAG. EBSCOhost, https://doi.org/10.1016/j.yexcr.2022.113077.
APA
Wang, Y., Bao, G., Zhang, M., Xiang, J., Zhou, H., Wahafu, A., Wu, W., Ma, X., Huo, L., Bai, X., Xie, W., Liu, P., & Wang, M. (2022). CRB2 enhances malignancy of glioblastoma via activation of the NF-κB pathway. Experimental Cell Research, 414(1), N.PAG. https://doi.org/10.1016/j.yexcr.2022.113077
Chicago
Wang, Yichang, Gang Bao, Miao Zhang, Jianyang Xiang, Haoyu Zhou, Alafate Wahafu, Wei Wu, et al. 2022. “CRB2 Enhances Malignancy of Glioblastoma via Activation of the NF-ΚB Pathway.” Experimental Cell Research 414 (1): N.PAG. doi:10.1016/j.yexcr.2022.113077.